Shared Savings Program Public Reporting
ACO Name and Location
Covenant ACO, Inc.
2107 Oxford Ave, Suite 200, Lubbock, TX, 79410, U.S.A.
ACO Primary Contact
Ashlyn Frazier
806-725-0711
Organizational Information
ACO Participants:
|
ACO Participants
|
ACO Participant in Joint Venture
|
|
Arthritis & Osteoporosis Associates, LLP
|
No
|
|
C. Michel Oliva, M.D., PA
|
No
|
|
CATHY MALOUF, M.D., PA
|
No
|
|
Christopher R. Rose, MD, PA
|
No
|
|
Covenant Medical Group
|
No
|
|
DAVID R. LONG M.D., P.A.
|
No
|
|
Ear Nose and Throat Associates of Lubbock, PA
|
No
|
|
Family First Healthcare Of Lubbock Llc
|
No
|
|
Grace Clinic of Lubbock
|
No
|
|
Hill Medical Associates, LLP
|
No
|
|
Hoa H. Tran, MD PA, dba Tran Physician Group
|
No
|
|
James Gage
|
No
|
|
Kirk J Tiemann, MD, PA
|
No
|
|
Lakhu Rohra
|
No
|
|
Lubbock Kidney Blood Pressure Clinic PA
|
No
|
|
Lubbock Nephrology Associates, PA
|
No
|
|
METHODIST HOSPITAL LEVELLAND
|
No
|
|
METHODIST HOSPITAL, PLAINVIEW, TEXAS
|
No
|
|
Owen Health Group, PLLC
|
No
|
|
ROBERT ORDONEZ
|
No
|
|
Schwarzentraub Foot Clinic, PC
|
No
|
|
SWAT Surgical Associates, LLP
|
No
|
|
West Texas Eye P A
|
No
|
|
WEST TEXAS NEUROLOGY CLINIC LLC
|
No
|
ACO Governing Body:
|
Member First Name
|
Member Last Name
|
Member Title/ Position
|
Member’s Voting Power
(Expressed as a percentage)
|
Membership Type
|
ACO Participant Legal Business Name, if applicable
|
|
Joshua
|
Hill
|
Chair
|
5%
|
ACO Participant Representative
|
Hill Medical Associates, LLP
|
|
Jared
|
Brinker
|
Vice Chair
|
5%
|
ACO Participant Representative
|
Grace Clinic of Lubbock
|
|
Benjamin
|
Batson
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Jeremy
|
Brown
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Allan
|
Camacho
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Christopher
|
Collins
|
Member
|
5%
|
ACO Participant Representative
|
Grace Clinic of Lubbock
|
|
Steven
|
Crow
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Ethan
|
Dalley
|
Member
|
5%
|
Community Stakeholder Representative
|
N/A
|
|
Jeremy
|
Dalton
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Dominique
|
Foster
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Swetha
|
Gadwala
|
Member
|
5%
|
Community Stakeholder Representative
|
N/A
|
|
Kompal
|
Parmar
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Christopher
|
Rose
|
Member
|
5%
|
ACO Participant Representative
|
Christopher R. Rose, MD, PA
|
|
Caleb
|
Sallee
|
Member
|
5%
|
ACO Participant Representative
|
SWAT Surgical Associates, LLP
|
|
Lauren
|
Schaub
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Karen
|
Soriano
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Jason
|
Strefling
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Kirk
|
Tiemann
|
Member
|
5%
|
ACO Participant Representative
|
Kirk J Tiemann, MD, PA
|
|
Andrew
|
West
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
|
Marissa
|
Yates
|
Member
|
5%
|
ACO Participant Representative
|
Covenant Medical Group
|
Member's voting power may have been rounded to reflect a total voting
power of 100 percent.
Key ACO Clinical and Administrative Leadership:
ACO Executive: Walter Cathey
Medical Director: Christopher Collins, MD
Compliance Officer: Amy Riedel
Quality Assurance/Improvement Officer: Lisa Barrington, Ashlyn Frazier
Associated Committees and Committee Leadership
|
|
Committee Leader Name and Position
|
Quality and Credentialing
|
Christopher Collins, MD, Chair
|
Population Health and Finance
|
|
Types of ACO Participants, or Combinations of Participants, That Formed the ACO:
Shared Savings and Losses
Amount of Shared Savings/Losses:
Note: Our ACO participated in multiple performance years during Calendar
Year 2019. The shared
savings/losses amount reported for Performance Year 2019 therefore represents
net shared savings or
losses across all performance years in 2019 and is shown under all agreement
periods in which the ACO
operated during Calendar Year 2019.
Shared Savings Distribution:
Note: Our ACO participated in multiple performance years during Calendar
Year 2019. The distribution of
shared savings reported for Performance Year 2019 therefore represents
the distribution of the net
shared savings across all performance years in 2019 and is shown under
all agreement periods in which
the ACO operated during Calendar Year 2019.
Quality Performance Results
2024 Quality Performance Results:
Quality performance results are based on the CMS Web Interface collection type.
|
|
|
|
|
Current Year Mean Performance Rate (Shared Savings Programs ACOs)
|
|
|
|
|
|
|
|
|
Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups
|
|
|
|
|
|
Clinician and Clinician Group Riskstandardized Hospital Admission Rates
for Patients with Multiple Chronic Conditions (MCC)
|
|
|
|
|
|
Falls: Screening for Future Fall Risk
|
|
|
|
|
|
Preventative Care and Screening: Influenza Immunization
|
|
|
|
|
|
Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention
|
|
|
|
|
|
Colorectal Cancer Screening
|
|
|
|
|
|
|
|
|
|
|
|
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
|
|
|
|
|
|
Depression Remission at Twelve Months
|
|
|
|
|
|
Diabetes: Hemoglobin A1c (HbA1c) Poor Control
|
|
|
|
|
|
Preventative Care and Screening: Screening for Depression and Follow-up Plan
|
|
|
|
|
|
Controlling High Blood Pressure
|
|
|
|
|
|
Getting Timely Care, Appointments, and Information
|
|
|
|
|
|
How Well Providers Communicate
|
|
|
|
|
|
Patient’s Rating of Provider
|
|
|
|
|
|
|
|
|
|
|
|
Health Promotion and Education
|
|
|
|
|
|
|
|
|
|
|
|
Health Status and Functional Status
|
|
|
|
|
|
|
|
|
|
|
|
Courteous and Helpful Office Staff
|
|
|
|
|
|
Stewardship of Patient Resources
|
|
|
|
For previous years’ Financial and Quality Performance Results, please
visit: Data.cms.gov
*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID
#001], Hospital-Wide, 30-Day,
All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician
Groups [Measure #479], and
Clinician and Clinician Group Risk-standardized Hospital Admission Rates
for Patients with Multiple
Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates
better measure
*For Clinician and Clinician Group Risk-standardized Hospital Admission
Rates for Patients with Multiple
Chronic Conditions (MCC) [Measure #484], patients are excluded if they
were attributed to Qualifying
Alternative Payment Model (APM) Participants (QPs). Most providers participating
in Track E and
ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED
track ACOs
may not be representative of the care provided by these ACOs' providers
overall. Additionally, many of
these ACOs do not have a performance rate calculated due to not meeting
the minimum of 18
beneficiaries attributed to non-QP providers.